NNOX at a glance
Nano-X Imaging Ltd. (NNOX, SEC CIK 1795251) filed Form 4 insider filings as recently as October 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- As of September 30, 2026, 15 institutional investment managers tracked by SignalX reported holding Nano-X Imaging Ltd. (NNOX) shares worth $1.6 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Meltzer Erez on October 19, 2026 of 25,000 shares at $0.45 per share.
- In the last 90 days, NNOX insiders reported 5 open-market purchases ($71K) and 0 open-market sales ($0) on Form 4, a net purchase of $71K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Insiders · 90 days
- 5 buys · 0 sells
- Net +$71K
- 13F holders
- 15 funds
- $1.6M · +0 vs prior quarter
SignalX for NNOX
Don't miss the next NNOX filing
- Alerts as it files. A push when NNOX files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NNOX, by share count.
- Ask anything. An AI agent that reads every NNOX filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Meltzer Erez | Buy | Oct 19, 2026 | 25,000 | $0.45 |
| saban sharon | A | Oct 14, 2026 | 28,283 | - |
| Nathansohn Guy | A | Oct 14, 2026 | 50,000 | - |
| Yahav Attias Gali | A | Oct 14, 2026 | 28,283 | - |
| Gofman Feler Marina | A | Oct 13, 2026 | 28,283 | - |
| Aharon Cohen Tamar | A | Oct 11, 2026 | 28,283 | - |
| Dara James | A | Oct 11, 2026 | 28,283 | - |
| Koren Ofir | A | Oct 10, 2026 | 28,283 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate NNOX share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 15 | $1.6M |
| Q2 2026 | 15 | $4.4M |
| Q1 2026 | 18 | $21.3M |
| Q4 2025 | 21 | $23.0M |
| Q3 2025 | 19 | $30.0M |
| Q2 2025 | 23 | $42.1M |
| Q1 2025 | 23 | $22.3M |
| Q4 2024 | 17 | $25.5M |
- Citadel Advisors LLC+130.2K (+922%)
- Goldman Sachs Group+115.2K (+33%)
- JPMorgan Chase & Co+30.1K (+1161%)
- Citigroup+160 (+16%)
- AQR Capital Management−512.2K (-91%)
- Morgan Stanley−298.1K (-46%)
- BlackRock−123.6K (-21%)
- Bank of America Corp−45.2K (-10%)
- StoneX Group Inc.−5.8K (-24%)
- Renaissance Technologies LLC+316.2K
- D.E. Shaw & Co+16.9K
- Raymond James Financial+10.4K
- Fifth Third Bancorp+12
- ARK Investment Management−806.6K
- State Street Corp−281.0K
- Millennium Management−13.3K
- FMR LLC (Fidelity)−3.5K
Source: 13F-HR filings on SEC EDGAR (aggregated from 151 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 6-K | Nov 12, 2026 | - | - | - |
| 6-K | Nov 12, 2026 | - | - | - |
| 6-K | Nov 10, 2026 | - | - | - |
| 6-K | Oct 28, 2026 | - | - | - |
| 6-K | Oct 28, 2026 | - | - | - |
| 4 | Oct 20, 2026 | - | - | - |
| 6-K | Oct 16, 2026 | - | - | - |
| 4 | Oct 14, 2026 | - | - | - |
| 4 | Oct 14, 2026 | - | - | - |
| 4 | Oct 14, 2026 | - | - | - |
| 4 | Oct 14, 2026 | - | - | - |
| 4 | Oct 13, 2026 | - | - | - |
| 4 | Oct 13, 2026 | - | - | - |
| 4 | Oct 13, 2026 | - | - | - |
| 6-K | Oct 2, 2026 | - | - | - |
| 6-K | Sep 29, 2026 | - | - | - |
| 6-K | Sep 17, 2026 | - | - | - |
| 4 | Sep 16, 2026 | - | - | - |
| 4 | Sep 15, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 6-K | Sep 9, 2026 | - | - | - |
| 6-K | Aug 18, 2026 | - | - | - |
| 6-K | Aug 13, 2026 | - | - | - |
| 4 | Aug 11, 2026 | - | - | - |
| 6-K | Aug 7, 2026 | - | - | - |
Related Health Care companies
- BFLY · Butterfly Network, Inc.X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- GEHC · GE HealthCareX-Ray Apparatus & Tubes & Related Irradiation Apparatus
- HOLX · HologicX-Ray Apparatus & Tubes & Related Irradiation Apparatus
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
NNOX SEC filings: frequently asked questions
Are NNOX insiders buying or selling?
In the last 90 days, Nano-X Imaging Ltd. (NNOX) officers, directors and 10% owners reported 5 open-market purchases worth $71,250 by 2 insiders and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold NNOX stock?
As of September 30, 2026, the largest Nano-X Imaging Ltd. (NNOX) holders among the 13F filers tracked by SignalX were BlackRock ($327,000), Goldman Sachs Group ($322,000), Bank of America Corp ($285,000), Morgan Stanley ($247,000), Renaissance Technologies LLC ($219,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What are the latest NNOX SEC filings?
Nano-X Imaging Ltd. (NNOX) filed a Form 4 insider filing on October 20, 2026.
What is NNOX's SEC CIK number?
Nano-X Imaging Ltd. (NNOX)'s SEC Central Index Key (CIK) is 1795251. EDGAR lists every NNOX filing under that number.
Ask anything about NNOX
The research agent reads NNOX's filings, financials, insider trades and 13F holders, then answers with sources.